Found: 222
Select item for more details and to access through your institution.
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse model.
- Published in:
- Annals of the New York Academy of Sciences, 2017, v. 1407, n. 1, p. 75, doi. 10.1111/nyas.13547
- By:
- Publication type:
- Article
Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Tetrabenazine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01077-w
- By:
- Publication type:
- Article
Clinical Exome/Genome Reports-Announcement.
- Published in:
- Clinical Genetics, 2015, v. 87, n. 2, p. 99, doi. 10.1111/cge.12556
- By:
- Publication type:
- Article
Developmental Biology: Frontiers for Clinical Genetics.
- Published in:
- Clinical Genetics, 2014, v. 86, n. 1, p. no, doi. 10.1111/cge.12429
- By:
- Publication type:
- Article
Special new feature in Clinical Genetics.
- Published in:
- Clinical Genetics, 2013, v. 83, n. 1, p. 1, doi. 10.1111/cge.12067
- By:
- Publication type:
- Article
Announcement.
- Published in:
- Clinical Genetics, 2010, v. 77, n. 4, p. 305, doi. 10.1111/j.1399-0004.2010.01420.x
- By:
- Publication type:
- Article
Introduction to Social and Behavioral Research in Genetics.
- Published in:
- Clinical Genetics, 2005, v. 68, n. 6, p. 571, doi. 10.1111/j.1399-0004.2005.00549.x
- By:
- Publication type:
- Article
Introduction to Social and Behavioural Research in Genetics.
- Published in:
- 2005
- By:
- Publication type:
- Other
Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches.
- Published in:
- Clinical Genetics, 2000, v. 57, n. 1, p. 1, doi. 10.1034/j.1399-0004.2000.570101.x
- By:
- Publication type:
- Article
Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women.
- Published in:
- Clinical Genetics, 1999, v. 56, n. 4, p. 297, doi. 10.1034/j.1399-0004.1999.560407.x
- By:
- Publication type:
- Article
Accurate determination of the number of CAG repeats in the Huntington disease gene using a sequence-specific internal DNA standard.
- Published in:
- Clinical Genetics, 1999, v. 55, n. 3, p. 198, doi. 10.1034/j.1399-0004.1999.550308.x
- By:
- Publication type:
- Article
The fatal attraction of polyglutamine-containing proteins.
- Published in:
- Clinical Genetics, 1998, v. 53, n. 4, p. 233, doi. 10.1111/j.1399-0004.1998.tb02687.x
- By:
- Publication type:
- Article
The new Clinical Genetics: towards the millennium.
- Published in:
- Clinical Genetics, 1998, v. 53, n. 1, p. 1, doi. 10.1034/j.1399-0004.1998.531530101.x
- By:
- Publication type:
- Article
The Asn9 variant of lipoprotein lipase is associated with the - 93G promoter mutation and an increased risk of coronary artery disease.
- Published in:
- Clinical Genetics, 1998, v. 53, n. 1, p. 27, doi. 10.1111/j.1399-0004.1998.tb02577.x
- By:
- Publication type:
- Article
Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase.
- Published in:
- Clinical Genetics, 1994, v. 46, n. 1, p. 15, doi. 10.1111/j.1399-0004.1994.tb04197.x
- By:
- Publication type:
- Article
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Axonal ER Ca<sup>2+</sup> Release Selectively Enhances Activity-Independent Glutamate Release in a Huntington Disease Model.
- Published in:
- Journal of Neuroscience, 2023, v. 43, n. 20, p. 3743, doi. 10.1523/JNEUROSCI.1593-22.2023
- By:
- Publication type:
- Article
Huntingtin Bodies Sequester Vesicle-Associated Proteins by a Polyproline-Dependent Interaction.
- Published in:
- Journal of Neuroscience, 2004, v. 24, n. 1, p. 269, doi. 10.1523/JNEUROSCI.1409-03.2004
- By:
- Publication type:
- Article
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 4082, doi. 10.3390/ijms22084082
- By:
- Publication type:
- Article
Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease.
- Published in:
- BMC Biology, 2018, v. 16, n. 1, p. 1, doi. 10.1186/s12915-018-0526-3
- By:
- Publication type:
- Article
Cholesterol in islet dysfunction and type 2 diabetes.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
- Published in:
- Journal of Clinical Investigation, 2005, v. 115, n. 5, p. 1333, doi. 10.1172/JCI200523915
- By:
- Publication type:
- Article
Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS.
- Published in:
- Nucleic Acids Research, 2013, v. 41, n. 21, p. 9634
- By:
- Publication type:
- Article
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
- Published in:
- American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 2018, v. 177, n. 3, p. 346, doi. 10.1002/ajmg.b.32618
- By:
- Publication type:
- Article
High frequency of intermediate alleles on huntington disease-associated haplotypes in British Columbia's general population.
- Published in:
- American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 2013, v. 162B, n. 8, p. 864, doi. 10.1002/ajmg.b.32193
- By:
- Publication type:
- Article
Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models.
- Published in:
- Nature Medicine, 2013, v. 19, n. 8, p. 1030, doi. 10.1038/nm.3246
- By:
- Publication type:
- Article
Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.
- Published in:
- Nature Medicine, 2011, v. 17, n. 3, p. 377, doi. 10.1038/nm.2313
- By:
- Publication type:
- Article
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.
- Published in:
- Nature Medicine, 2009, v. 15, n. 12, p. 1407, doi. 10.1038/nm.2056
- By:
- Publication type:
- Article
β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.
- Published in:
- Nature Medicine, 2007, v. 13, n. 3, p. 340, doi. 10.1038/nm1546
- By:
- Publication type:
- Article
P3-377: A novel pathogenic pathway of immune activation detectable before cinical onset in Huntington's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-053: Alzheimer’s disease neuropathology is not mitigated by the physiological expression of human ABCA1 in APP/PS1 mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-053: Alzheimer’s disease neuropathology is not mitigated by the physiological expression of human ABCA1 in APP/PS1 mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.
- Published in:
- Nature Genetics, 2015, v. 47, n. 9, p. 1079, doi. 10.1038/ng.3374
- By:
- Publication type:
- Article
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.
- Published in:
- Nature Genetics, 2013, v. 45, n. 5, p. 578, doi. 10.1038/ng.0513-578
- By:
- Publication type:
- Article
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.
- Published in:
- Nature Genetics, 2009, v. 41, n. 12, p. 1345, doi. 10.1038/ng.478
- By:
- Publication type:
- Article
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
- Published in:
- Nature Genetics, 2003, v. 35, n. 1, p. 76, doi. 10.1038/ng1219
- By:
- Publication type:
- Article
Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.
- Published in:
- Nature Genetics, 2002, v. 32, n. 2, p. 326, doi. 10.1038/ng957
- By:
- Publication type:
- Article
Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner cataract.
- Published in:
- Nature Genetics, 2002, v. 31, n. 3, p. 276, doi. 10.1038/ng921
- By:
- Publication type:
- Article
The genetic aspects of atherosclerosis and hyperlipidemia.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1989, v. 141, n. 2, p. 135
- By:
- Publication type:
- Article
Genotypic Approaches to Therapy in Children.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1110, p. 177, doi. 10.1196/annals.1423.020
- By:
- Publication type:
- Article
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.
- Published in:
- Scientific Reports, 2016, p. 31652, doi. 10.1038/srep31652
- By:
- Publication type:
- Article
Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes.
- Published in:
- Scientific Reports, 2016, p. 25333, doi. 10.1038/srep25333
- By:
- Publication type:
- Article
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00443-8
- By:
- Publication type:
- Article
Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107434
- By:
- Publication type:
- Article
Striatal Synaptic Dysfunction and Hippocampal Plasticity Deficits in the Hu97/18 Mouse Model of Huntington Disease.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094562
- By:
- Publication type:
- Article
Identification of Binding Sites in Huntingtin for the Huntingtin Interacting Proteins HIP14 and HIP14L.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0090669
- By:
- Publication type:
- Article
Comparing the Biological Impact of Glatiramer Acetate with the Biological Impact of a Generic.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0083757
- By:
- Publication type:
- Article